Cellular cardiomyoplasty as supportive therapy in patients with heart disease
US8889122B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | May 9, 2006 |
| Grant date | Nov 18, 2014 |
| Priority date | — |
| Expiry date | Aug 27, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K35/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a system for treating heart disease as a “bridge to recovery” using cellular cardiomyoplasty. The system is particularly useful in selecting and treating patients with damaged myocardium due coronary artery disease, myocardial infarction, congestive heart failure, and ischemia. Based on various clinical criteria, a patient is selected and optionally treated using cellular cardiomyoplasty to improve the patient's cardiac function. The cardiomyoplasty may be combined with other treatments such as medications or left ventricular assist devices. Preferably, the cellular cardiomyoplasty eliminates the need for invasive surgery such as by-pass grafting or cardiac transplantation. The invention also provides kits for use in selecting and treating patients using the inventive method.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.